Polyomavirus late nuclear primary transcripts contain tandem repeats of the late strand of the viral genome, as a result of inefficient transcription termination and polyadenylation. Pre-mRNA processing involves the splicing of short noncoding late leader exons to each other (removing genome-length introns) and the splicing of the last leader to a coding body exon (such as for the major virion structural protein, VP1). As a result, cytoplasmic mRNAs contain 1 to 12 tandem leader exons at their 5' ends that are followed by a single coding exon. To understand more about how polyomavirus exons are spliced together, we studied a double-genome construct consisting of two tandem but nonidentical polyomavirus late transcription units. The alternating leader exons are distinguishable from one another but retain identical flanking RNA-processing signals, as for the alternating VP1 exons. We transfected this construct and derivatives of it into mouse cells and determined which leader exons are spliced to which others and which VP1 exons are utilized. Results showed that leader exons are almost never skipped during splicing and are spliced sequentially to one another. On the other hand, VP1 exons were often skipped, with the VP1 exon closest to the polyadenylation site splicing to the nearest upstream leader exon. Splice site replacement experiments showed that VP1 exon skipping is not due to a relative weakness of its 3' splice site or to any sequence upstream of the VP1 3' splice site. Exon skipping is also not the result of sequences within the VP1 exon. Rather, VP1 3' splice site skipping can be eliminated by replacing the inefficient late polyadenylation signal with an efficient one, or by inserting a 5' splice site between the VPI 3' splice site and the late polyadenylation site. Thus, sequences that compose the distal border of the VP1 exon can influence usage of the upstream 3' splice site.
Polyomavirus late nuclear primary transcripts contain tandem repeats of the late strand of the viral genome, as a result of inefficient transcription termination and polyadenylation. Pre-mRNA processing involves the splicing of short noncoding late leader exons to each other (removing genome-length introns) and the splicing of the last leader to a coding body exon (such as for the major virion structural protein, VP1). As a result, cytoplasmic mRNAs contain 1 to 12 tandem leader exons at their 5' ends that are followed by a single coding exon. To understand more about how polyomavirus exons are spliced together, we studied a double-genome construct consisting of two tandem but nonidentical polyomavirus late transcription units. The alternating leader exons are distinguishable from one another but retain identical flanking RNA-processing signals, as for the alternating VP1 exons. We transfected this construct and derivatives of it into mouse cells and determined which leader exons are spliced to which others and which VP1 exons are utilized. Results showed that leader exons are almost never skipped during splicing and are spliced sequentially to one another. On the other hand, VP1 exons were often skipped, with the VP1 exon closest to the polyadenylation site splicing to the nearest upstream leader exon. Splice site replacement experiments showed that VP1 exon skipping is not due to a relative weakness of its 3' splice site or to any sequence upstream of the VP1 3' splice site. Exon skipping is also not the result of sequences within the VP1 exon. Rather, VP1 3' splice site skipping can be eliminated by replacing the inefficient late polyadenylation signal with an efficient one, or by inserting a 5' splice site between the VPI 3' splice site and the late polyadenylation site. Thus, sequences that compose the distal border of the VP1 exon can influence usage of the upstream 3' splice site.
Polyomavirus late pre-mRNA molecules contain optional splice sites and polyadenylation sites. Polyomavirus late transcription termination and polyadenylation are both inefficient, leading to the production of a heterogeneous collection of nuclear primary transcripts, some of which are many times the size of the viral genome (1-3, 37, 38) . Figure 1 illustrates the current model for how one such giant premRNA molecule is processed into a mature cytoplasmic message for the major viral structural protein, VP1. At the 5' ends of late primary transcripts is a noncoding exon, the late leader. In giant transcripts, this exon appears multiple times. During RNA processing, leaders are spliced to each other, skipping internal VP1 exons and removing genome-length introns. In addition, for mVP1 molecules a body splice site is chosen to attach the final late leader exon to a terminal coding exon. Thus, mature late cytoplasmic messages contain, at their 5' ends, 1 to 12 tandem copies of the late leader exon that are followed by a single coding exon (20, 21, 25, 36) . The average late message contains three to four tandem late leader units (36) . An interesting feature of this system is that the splice sites and polyadenylation sites that are chosen are identical to those that are skipped.
We have been interested in understanding how exons are spliced to each other during polyomavirus late pre-mRNA processing. To begin to address this issue, we have made a series of constructs containing a duplicated viral genome, but with distinct late leader and VP1 exons. We have focused on the expression of the message for VP1, the major capsid protein, because it accounts for 80 to 85% of late viral message (21, 35 were rarely skipped. VP1 exons, however, were often skipped, with the 3'-terminal VP1 exon splicing to the nearest upstream leader. Splice site and polyadenylation signal replacement experiments showed that VP1 exon skipping is not due to a relatively weak 3' splice site that is often ignored. Rather, skipping of the VP1 3' splice site is strongly influenced by the strength of the nearest downstream polyadenylation site and by the presence of a downstream 5' splice site. These results suggest that exon skipping in polyomavirus is normally due to inefficient recognition of the late polyadenylation site and provide in vivo support for the exon definition model recently proposed by Robberson et (17, 18) . This strain is very similar in its nucleotide sequence to that published for strain A3 (14 (10) . Briefly, cells were scraped into PBS-and pelleted by centrifugation at 1,000 x g for 3 min. The pellet was resuspended in PBS-and centrifuged again at 1,000 x g for 3 min. The cell pellet was resuspended in 3 ml of Nonidet P-40 lysis buffer and left on ice for 10 min. Nuclei were removed by centrifugation at 1,000 x g for 3 min. To the supernatant (the cytoplasmic RNA fraction) was added 1.42 g of guanidine isothiocyanate powder. RNA was separated from DNA by centrifugation through a 5.7 M cesium chloride cushion for 20 h at 110,000 x g (12) . The pelleted RNAs were drained well and resuspended in 300 RI of 10 mM Tris-Cl (pH 7.0)-i mM EDTA (pH 7.0)-0.2% sodium dodecyl sulfate and ethanol precipitated. RNAs were resuspended in 100 Il of distilled H20.
Construction of plasmids. All cloning was done by standard procedures. The structures of the major plasmids used in this study are shown schematically in Fig. 2 .
(i) Double-genome constructs. The construction of plasmids pl-13 and pl-16 is described in detail elsewhere (27a Before transfection, each was digested with EcoRI, which liberated the polyomavirus sequences from the plasmid backbone, and recircularized with T4 DNA ligase. 1-13 contains two copies of the viral late region, but the first copy has a substituted late leader exon sequence (SLM [6] ), while the second has a truncated VP1-coding exon (VP1'). 1-13 5'ss is the same as 1-13, except the late leader 5' splice site has been inserted into the coding region of VP1, 80 nt downstream of the VP1 3' splice site. 1-16 is the same as 1-13, except for deletion of sequences including one intact early coding region, replication origin, late promoter, and late leader exon. L-LVP1 (8) is a single-leader mVP1 cDNA which also contains an upstream single-leader exon (flanked by its normal splice sites) and an intron of 165 nt. The important splice sites in these constructs are indicated. There is a minor 3' splice site (not shown) between the late leader and the VP1 3' splice site for the production of messages encoding VP3. AA, polyadenylation signal AAUAAA. (ii) Construct L-LVP1. Plasmid L-LVP1 was made by inserting a 165-bp fragment containing the late leader exon and flanking sequences (including the late promoter just upstream of the late leader 3' splice site) into a genome in which the VP1 intron had been precisely removed by oligonucleotide-directed mutagenesis. This construct was originally made for other experiments in the laboratory and has been described in detail elsewhere (8) .
PCR assays. Oligonucleotide primers were made by using a Milligen/Biosearch Cyclone DNA Synthesizer and the phosphoramidite chemistry. Oligonucleotide 275 (5'-TATCA CCGTACAGCCTTG) anneals across the VP1-late leader splice junction, with the terminal 3 bases annealing to the late leader and the rest annealing to the VP1-coding exon.
Oligonucleotide 278 (5'-CCTGACATTTTCTATTTTAAG) anneals to late cDNA molecules immediately upstream of the late leader exon. Oligonucleotide PE (5'-CTATGACT GTTGCCC) anneals to late mRNA just inside the VP1 exon. Oligonucleotide 279 (5'-TCCTAGATGAAAATGGAG) anneals to the truncated VP1' exon but not to the wild-type VP1 exon.
The polymerase chain reaction (PCR) (34) was performed following reverse transcription of the RNA. Oligonucleotide 275, 279, or PE was added to the RNA in a buffer recommended by Perkin-Elmer Cetus. AMV reverse transcriptase (22 U) was added and allowed to incubate for 1 h at 45°C. TaqI DNA polymerase and oligonucleotide 278 were then added, and PCR continued for 30 cycles. Each cycle had three sections. The first was a 2-min incubation at 92°C. After a 30-s ramp time, the incubation was continued for 1 min at 45°C. Finally, after a 0.5-min ramp time to 72°C, incubation was continued for 1.5 min. A 10-min incubation at 72°C followed the final cycle. Reaction products were resolved on 6% polyacrylamide-urea gels, and bands were detected by autoradiography. It is important to note that the PCR amplification of RNA performed in our analyses accurately and reliably reflected the RNA amounts in our samples. Such verification has previously been presented by our laboratory (20) .
RESULTS
Constructs and experimental design. We constructed a series of plasmids that contain duplicated viral genomes, but with distinguishable late leader and VP1 exons. Each of the constructs used contains at least one intact early coding region and DNA replication origin, so each produces early viral proteins and replicates in transfected mouse cells. Figure 2 illustrates schematically the intron-exon structures of the constructs used in the work described here. The primary construct is 1-13: it has two distinguishable leader exons and two distinguishable VP1 exons. The wild-type (WT) and substituted (SLM) late leaders are of different sequence and differ by 6 nucleotides in length. We have shown previously that a virus with the SLM leader used here grows like wild type and is not defective in late pre-mRNA processing (4, 6 (20) . Figure 3 shows the results of such a PCR experiment using oligonucleotide 275, which binds to the junction of the leader-to-VP1 splice as well as to the junction of the leaderto-VP1' splice. (SLM) . At the one-leader level, almost all the signal observed for 1-13 was at the SLM leader position when using a VP1-specific probe and at the wildtype position when using a VP1'-specific probe. This indicates that in this construct, most VP1 or VP1' splicing is to the immediately upstream leader exon. Again, the leaders were not skipped during pre-mRNA splicing, while the VP1 and VP1' exons were both skipped. Since the VP1' exon retains only 81 nt deriving from the wild-type VP1 exon [14 nt adjacent to the VP1 3' splice site and 67 nt just upstream of the poly(A) site], exon skipping is not likely to be the result of sequences within the late viral coding region that inhibit the use of the VP1 3' splice site. We cannot exclude, however, that these sequences might somehow influence the use of the VP1 3' splice site. Figure 4B illustrates some of the splicing events demonstrated by these data. 
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Exons are not skipped because the VP1 3' splice site is weaker than the late leader 3' splice site. Figure 4A also shows that leader splicing in 1-16 can occur to either the VP1 or the VP1' exon, indicating that exon skipping does not have to involve splicing only to a downstream leader exon. This construct contains only an SLM leader, which is upstream of a VP1 exon. The distal VP1' exon has no leader immediately upstream of it. As seen in Fig. 4A , however, the VP1' exon can still be spliced efficiently to the SLM leader exon, following skipping of the upstream VP1 exon, indicating that VP1 exon skipping does not result from the presence of a downstream leader exon and is therefore not likely to be the result of especially strong leader splice sites that outcompete the VP1 3' splice site.
A possible explanation for VP1 exon skipping in polyomavirus would be that the VP1 exon has an inherently inefficient 3' splice site which is poorly recognized by the splicing machinery of the cell. To determine whether this model is correct, we analyzed construct L-LVP1. In L-LVP1, the VP1 3' splice site has been replaced with the late leader 3' splice site. Thus, a 3' splice site that is frequently skipped has been replaced with one that is rarely skipped. In addition, this construct lacks almost all viral sequences that normally exist upstream of the VP1 exon. Cytoplasmic RNAs from L-LVP1 and wild-type polyomavirus were subjected to PCR analysis, and the results are shown in Fig. 5 . Bands at the one-, two-, and three-leader positions are shown. Clearly, L-LVP1 generated late messages with multiple leader structures, so the modified VP1 exon of this construct must be skipped. The important result here is that the ratio of mRNAs with two leaders to those with three leaders for L-LVP1 is the same as the ratio of mRNAs with one leader to those with two leaders for wild type. Quantitation of these results with a Betagen Betascope Blot Analyzer revealed that in this experiment the frequency of exon skipping for wild type was about 40%, while the frequency for L-LVP1 was about 25%. In other experiments, the frequency of splice site skipping in wild type and L-LVP1 has been virtually identical. We conclude from these experiments that VP1 skipping does not occur because the VP1 3' splice site is weaker than the late leader 3' splice site, or because sequences upstream of the VP1 3' splice site inhibit its use.
Late polyadenylation signal strength affects exon skipping. Since VP1 exon skipping appears not to result from relatively strong or weak splice sites or from intron or exon sequences flanking the VP1 3' splice site, we asked whether skipping might be influenced by the late polyadenylation signal. We therefore analyzed a viral variant, ins5, provided by N. Acheson. This mutant contains two tandem polyadenylation sites in the late transcription unit: one is the wild-type late polyadenylation site, and the other, just upstream, is a different, more efficient rabbit 3-globin polyadenylation site (23) . Wild-type or mutant viral genomes were transfected into mouse cells as in earlier experiments, and the resultant cytoplasmic RNA was subjected to a leader PCR assay. The results are shown in Fig. 6 . As expected, wild type produced a large proportion of VP1 messages with multiple leaders. In contrast, however, mutant ins5 produced only a few late mVP1 molecules which had more than a single leader, demonstrating that an efficient polyadenylation signal can suppress exon skipping. Quantitation with a Betagen Betascope Blot Analyzer revealed that ins5 produces about 95% single-leader molecules in this assay. These results for ins5 are in good agreement with those reported earlier by Lanoix and Acheson (23) for the polyadenylation efficiency of this mutant.
A 5' splice site within the VP1 exon can prevent exon skipping. The suppression of exon skipping by an efficient polyadenylation signal is difficult to interpret. Efficient polyadenylation is usually associated with efficient transcription termination, as has been reported even for mutant ins5 (23) . Thus, the results shown in Fig. 6 might be the trivial result of limited splicing choices in short transcripts. However, VP1 exon skipping could also be suppressed by another type of mutation. Construct 1-13 5'ss is identical to 1-13, except a small DNA fragment comprising the late leader 5' splice site has been inserted downstream of the VP1 3' splice site. PCR analysis with oligonucleotide 279 (specific for the VP1' exon) was used to examine exon skipping frequency in this mutant, and the results are shown in Fig. 7 . Strikingly, the VP1 exon in this construct is now almost never skipped, as evidenced by the virtual absence of a band representing two tandem leaders spliced to the VP1' exon. Rather, the SLM leader is spliced efficiently to the VP1 3' splice site, and the inserted 5' splice site is used to splice to the downstream wild-type leader exon (top band in the I-13 5'ss lane). As would be expected, the VP1' exon is still efficiently skipped (data not shown). (Fig. 3 and 4) . On the other hand, VP1-coding exons are often skipped. Here we showed that when a VP1 3' splice site is selected for use, it is spliced to the nearest upstream late leader unit (Fig. 4) (Fig. 4) (32) . In that model, both boundaries of an exon must be recognized, or defined, before RNA processing can occur at either one. Thus, for internal exons, a 3' splice site and a downstream 5' splice site must both be recognized; for terminal exons, a polyadenylation signal could replace a 5' splice site. For a terminal exon, if the polyadenylation signal was not recognized, then the terminal exon would not be properly defined, and the VP1 3' splice site could not be used. Although one might envision regulation of VP1 exon skipping as occurring at either end of this terminal exon, i.e., through an inefficient VP1 3' splice site or through an inefficient late polyadenylation site, the data presented here strongly suggest that the exon skipping observed in polyomavirus is due to the inefficiency of the late polyadenylation site.
The model presented for the coordinate choice of a splice site and a polyadenylation site is consistent with a number of published observations on alternative splice site and polyadenylation site choice in naturally occurring complex transcription units. In such systems, there is growing evidence that polyadenylation and splicing are not independent processes, i.e., regulation at either end of a terminal exon can affect exon skipping or polyadenylation site choice. In one example of cell-specific regulation, studies on the switch between secreted and membrane forms of immunoglobulin M ,u heavy chain have suggested that this switch is regulated at the level of polyadenylation site choice (15, 19, 22, 28, 33) . In the immunoglobulin M system, choice of alternative polyadenylation signals leads to altered splicing pathways, and there may be competition between splicing and polyadenylation (30, 31) . In contrast, the expression of calcitonin and the calcitonin gene-related peptide, although controlled in a cell-specific manner from a complex transcription unit containing two polyadenylation sites, appears to be regulated at the step of splice site recognition, which in turn leads to the use of the nearest downstream polyadenylation signal (7, 16, 24) .
Other results from a number of recent studies have been interpreted as demonstrating that splicing dominates over polyadenylation. If an efficient polyadenylation site is placed within an intron, then it can be skipped; if the same site is placed within an exon, or if surrounding splice sites are mutated, then it is used (5, 9, 26). Niwa et al. (29) have suggested that placement of a polyadenylation site within an intron inactivates polyadenylation not because the polyadenylation machinery cannot compete with the splicing machinery, but because it cannot interact with it, reflecting an underlying polarity of pre-mRNA processing signals. Our results are consistent with this view.
